Literature DB >> 5477702

Vitamin E therapy in abetalipoproteinaemia.

D R Muller, J T Harries, J K Lloyd.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5477702      PMCID: PMC1647524          DOI: 10.1136/adc.45.243.715-a

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  5 in total

1.  Abetalipoproteinemia in an Indian family.

Authors:  M V Padma; S Jain; M C Maheshwari
Journal:  Indian J Pediatr       Date:  1996 Mar-Apr       Impact factor: 1.967

2.  Absorption of different doses of fat soluble and water miscible preparations of vitamin E in children with cystic fibrosis.

Authors:  J T Harries; D P Muller
Journal:  Arch Dis Child       Date:  1971-06       Impact factor: 3.791

3.  Absorption of vitamin E in children with biliary obstruction.

Authors:  J T Harries; D P Muller
Journal:  Gut       Date:  1971-07       Impact factor: 23.059

4.  Combined vitamin A and E therapy prevents retinal electrophysiological deterioration in abetalipoproteinaemia.

Authors:  S Bishara; S Merin; M Cooper; E Azizi; G Delpre; R J Deckelbaum
Journal:  Br J Ophthalmol       Date:  1982-12       Impact factor: 4.638

5.  Normotriglyceridemic abetalipoproteinemia. absence of the B-100 apolipoprotein.

Authors:  M J Malloy; J P Kane; D A Hardman; R L Hamilton; K B Dalal
Journal:  J Clin Invest       Date:  1981-05       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.